Anthropic has reportedly acquired Coefficient Bio for $400 million in an all-stock deal, integrating its AI-biotech expertise into Anthropic's Health Care Life Sciences group. This acquisition appears to precede the launch of Fable 5, a new model that allegedly degrades outputs for life science research, including biology, chemistry, drug discovery, and protein work. The move has drawn criticism, as the capabilities Fable 5 appears to restrict are precisely those that Coefficient Bio specializes in and that Anthropic sought to acquire. AI
IMPACT Raises questions about AI labs restricting research in areas they acquire, potentially limiting scientific progress.
RANK_REASON Significant acquisition by a major AI lab, followed by a controversial product decision. [lever_c_demoted from significant: ic=1 ai=1.0]
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
